Cardiology Devices - Italy | Statista Market Forecast

In Italy, the revenue of the Cardiology Devices market market is estimated to reach US$1.72bn by 2024.
The market is anticipated to grow at an annual growth rate (CAGR 2024-2029) of 3.67%, leading to a market volume of US$2.06bn by 2029.
When compared globally, the United States is projected to generate the highest revenue in the Cardiology Devices market market, with US$25.77bn in 2024.
Italy is a leading market for cardiology devices, with a strong focus on innovative and minimally invasive technologies.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

The Cardiology Devices market in Italy is experiencing steady growth due to increasing customer preferences for advanced medical technologies and rising prevalence of cardiovascular diseases.

Customer preferences: Italian customers in the Cardiology Devices market are increasingly demanding innovative and technologically advanced products. They are willing to invest in cutting-edge devices that offer accurate diagnosis and effective treatment options for cardiovascular conditions. The preference for minimally invasive procedures and non-invasive monitoring devices is also growing among patients, as these methods offer faster recovery times and reduced risks.

Trends in the market: One of the key trends in the Cardiology Devices market in Italy is the adoption of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. These devices are used for the management of heart failure and arrhythmias, and their demand is increasing due to the rising prevalence of these conditions. Additionally, there is a growing trend towards remote monitoring of cardiac devices, which allows healthcare professionals to monitor patients' conditions and adjust treatment plans remotely, thereby reducing the need for frequent hospital visits. Another trend in the market is the increasing use of transcatheter aortic valve replacement (TAVR) procedures. This minimally invasive technique allows for the replacement of a diseased aortic valve without the need for open-heart surgery. The demand for TAVR procedures is rising as they offer shorter recovery times and better outcomes compared to traditional surgical methods.

Local special circumstances: Italy has a high prevalence of cardiovascular diseases, with a significant portion of the population suffering from conditions such as hypertension, coronary artery disease, and heart failure. This has created a large customer base for Cardiology Devices in the country. Additionally, the Italian government has been actively promoting the use of advanced medical technologies and has implemented reimbursement policies that support the adoption of innovative Cardiology Devices.

Underlying macroeconomic factors: The growing Cardiology Devices market in Italy is also influenced by several macroeconomic factors. The country has a well-developed healthcare system with a strong emphasis on research and development. This has led to the availability of a wide range of Cardiology Devices in the market. Furthermore, the increasing healthcare expenditure in Italy, coupled with the aging population, is driving the demand for Cardiology Devices as the elderly are more susceptible to cardiovascular diseases. The favorable reimbursement policies and the presence of key market players in the country also contribute to the growth of the Cardiology Devices market in Italy.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.